Targeting virulence: can we make evolution-proof drugs?
- PMID:24625893
- DOI: 10.1038/nrmicro3232
Targeting virulence: can we make evolution-proof drugs?
Abstract
Antivirulence drugs are a new type of therapeutic drug that target virulence factors, potentially revitalising the drug-development pipeline with new targets. As antivirulence drugs disarm the pathogen, rather than kill or halt pathogen growth, it has been hypothesized that they will generate much weaker selection for resistance than traditional antibiotics. However, recent studies have shown that mechanisms of resistance to antivirulence drugs exist, seemingly damaging the 'evolution-proof' claim. In this Opinion article, we highlight a crucial distinction between whether resistance can emerge and whether it will spread to a high frequency under drug selection. We argue that selection for resistance can be reduced, or even reversed, using appropriate combinations of target and treatment environment, opening a path towards the development of evolutionarily robust novel therapeutics.
Similar articles
- Important Complexities of the Antivirulence Target Paradigm: A Novel Ostensibly Resistance-Avoiding Approach for Treating Infections.Russo TA, Spellberg B, Johnson JR.Russo TA, et al.J Infect Dis. 2016 Mar 15;213(6):901-3. doi: 10.1093/infdis/jiv533. Epub 2015 Nov 12.J Infect Dis. 2016.PMID:26563238Free PMC article.Review.
- Targeting virulence: a new paradigm for antimicrobial therapy.Clatworthy AE, Pierson E, Hung DT.Clatworthy AE, et al.Nat Chem Biol. 2007 Sep;3(9):541-8. doi: 10.1038/nchembio.2007.24.Nat Chem Biol. 2007.PMID:17710100Review.
- The arsenal of pathogens and antivirulence therapeutic strategies for disarming them.Brannon JR, Hadjifrangiskou M.Brannon JR, et al.Drug Des Devel Ther. 2016 May 27;10:1795-806. doi: 10.2147/DDDT.S98939. eCollection 2016.Drug Des Devel Ther. 2016.PMID:27313446Free PMC article.Review.
- Antimicrobials for bacterial bioterrorism agents.Sarkar-Tyson M, Atkins HS.Sarkar-Tyson M, et al.Future Microbiol. 2011 Jun;6(6):667-76. doi: 10.2217/fmb.11.50.Future Microbiol. 2011.PMID:21707313Review.
- Novel agents to inhibit microbial virulence and pathogenicity.Escaich S.Escaich S.Expert Opin Ther Pat. 2010 Oct;20(10):1401-18. doi: 10.1517/13543776.2010.511176.Expert Opin Ther Pat. 2010.PMID:20718591Review.
Cited by
- Targeting virulence regulation to disarmAcinetobacter baumannii pathogenesis.Trebosc V, Lucchini V, Narwal M, Wicki B, Gartenmann S, Schellhorn B, Schill J, Bourotte M, Frey D, Grünberg J, Trauner A, Ferrari L, Felici A, Champion OL, Gitzinger M, Lociuro S, Kammerer RA, Kemmer C, Pieren M.Trebosc V, et al.Virulence. 2022 Dec;13(1):1868-1883. doi: 10.1080/21505594.2022.2135273.Virulence. 2022.PMID:36261919Free PMC article.
- Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment.Gjini E, Brito PH.Gjini E, et al.PLoS Comput Biol. 2016 Apr 14;12(4):e1004857. doi: 10.1371/journal.pcbi.1004857. eCollection 2016 Apr.PLoS Comput Biol. 2016.PMID:27078624Free PMC article.
- Core principles of bacterial autoinducer systems.Hense BA, Schuster M.Hense BA, et al.Microbiol Mol Biol Rev. 2015 Mar;79(1):153-69. doi: 10.1128/MMBR.00024-14.Microbiol Mol Biol Rev. 2015.PMID:25694124Free PMC article.
- Tanshinones: First-in-Class Inhibitors of the Biogenesis of the Type 3 Secretion System Needle ofPseudomonas aeruginosa for Antibiotic Therapy.Feng C, Huang Y, He W, Cheng X, Liu H, Huang Y, Ma B, Zhang W, Liao C, Wu W, Shao Y, Xu D, Su Z, Lu W.Feng C, et al.ACS Cent Sci. 2019 Jul 24;5(7):1278-1288. doi: 10.1021/acscentsci.9b00452. Epub 2019 Jun 26.ACS Cent Sci. 2019.PMID:31403076Free PMC article.
- Mathematical model predicts anti-adhesion-antibiotic-debridement combination therapies can clear an antibiotic resistant infection.Roberts PA, Huebinger RM, Keen E, Krachler AM, Jabbari S.Roberts PA, et al.PLoS Comput Biol. 2019 Jul 23;15(7):e1007211. doi: 10.1371/journal.pcbi.1007211. eCollection 2019 Jul.PLoS Comput Biol. 2019.PMID:31335907Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials